Manejo de tumores perioculares mediante derivación a cirugía de Mohs y sus características clínico-histológicas

Q3 Medicine

Archivos De La Sociedad Espanola De Oftalmologia Pub Date : 2025-03-01 DOI:10.1016/j.oftal.2024.07.004

J.M. Ruiz Caro Larrea, S. Simpson, G.-Y. Wong, D. Ah-kine, A. Gibson, T.M. Lupión Durán

{"title":"Manejo de tumores perioculares mediante derivación a cirugía de Mohs y sus características clínico-histológicas","authors":"J.M. Ruiz Caro Larrea, S. Simpson, G.-Y. Wong, D. Ah-kine, A. Gibson, T.M. Lupión Durán","doi":"10.1016/j.oftal.2024.07.004","DOIUrl":null,"url":null,"abstract":"<div><h3>Antecedents and Objectives</h3><div>The aim of our study was to showcase that micrographic Mohs surgery (MMS) can be used efficiently even if unavailable (James Cook Hospital) in the management of periocular tumors through MMS via referral (Royal Victoria Infirmary Hospital), and describe our patients’ clinical and histological features.</div></div><div><h3>Materials and methods</h3><div>We conducted a retrospective, longitudinal and descriptive study with 58 patients. We categorized our patients in 3 groups; pre-COVID-19: patients from January 2019 through January 28<sup>th</sup> 2020, COVID-19: patients from January 29<sup>th</sup> 2020 through July 2021 and late COVID-19: patients from August 2021 through July 24<sup>th</sup> 2023.</div></div><div><h3>Results</h3><div>No differences across groups were reported; the date of first consultation (DFC) and MMS (<em>P</em>    =.19), and the time of lesion onset (<em>P</em>  =.60), the DFC and MMS (<em>P</em>  =.27). Nearly 16% of patients were discharged during their first postoperative visit.</div></div><div><h3>Conclusion</h3><div>The combined management of periocular tumors across 2 hospitals proved effective, even though the COVID-19 pandemic.</div></div>","PeriodicalId":8348,"journal":{"name":"Archivos De La Sociedad Espanola De Oftalmologia","volume":"100 3","pages":"Pages 119-124"},"PeriodicalIF":0.0000,"publicationDate":"2025-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Archivos De La Sociedad Espanola De Oftalmologia","FirstCategoryId":"1085","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S036566912400128X","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"Medicine","Score":null,"Total":0}

引用次数: 0

Abstract

Antecedents and Objectives

The aim of our study was to showcase that micrographic Mohs surgery (MMS) can be used efficiently even if unavailable (James Cook Hospital) in the management of periocular tumors through MMS via referral (Royal Victoria Infirmary Hospital), and describe our patients’ clinical and histological features.

Materials and methods

We conducted a retrospective, longitudinal and descriptive study with 58 patients. We categorized our patients in 3 groups; pre-COVID-19: patients from January 2019 through January 28^th 2020, COVID-19: patients from January 29^th 2020 through July 2021 and late COVID-19: patients from August 2021 through July 24^th 2023.

Results

No differences across groups were reported; the date of first consultation (DFC) and MMS (P = .06), the date of the referral request (DRR) and MMS (p = 0,054), the MMS date to reconstruction (P = .19), and the time of lesion onset (P = .054). The type of reconstruction was not impacted by the number of days between the clinic date and reconstruction (P = .60), the DFC and MMS (P = .60), and the DRR and MMS (P = .27). Nearly 16% of patients were discharged during their first postoperative visit.

Conclusion

The combined management of periocular tumors across 2 hospitals proved effective, even though the COVID-19 pandemic.

查看原文本刊更多论文

通过莫氏手术转诊治疗眼周肿瘤及其临床组织学特征

实验前提和目的本研究的目的是展示即使无法获得显微莫氏手术（James Cook医院），也可以有效地利用显微莫氏手术（MMS）通过转介（皇家维多利亚医院）通过MMS治疗眼周肿瘤，并描述我们患者的临床和组织学特征。材料与方法我们对58例患者进行了回顾性、纵向和描述性研究。我们将患者分为三组；COVID-19前期：2019年1月至2020年1月28日的患者，COVID-19前期：2020年1月29日至2021年7月的患者，COVID-19晚期：2021年8月至2023年7月24日的患者。结果各组间无差异；首次会诊日期（DFC）和MMS （P = 0.06）、转诊请求日期（DRR）和MMS （P = 0.054）、MMS重建日期（P = 0.19）和病变发生时间（P = 0.054）。重建类型不受临床日期和重建之间的天数（P = 0.60）、DFC和MMS （P = 0.60）以及DRR和MMS （P = 0.27）的影响。近16%的患者在术后第一次就诊时出院。结论在2019冠状病毒病疫情下，两家医院对眼周肿瘤的联合治疗是有效的。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Archivos De La Sociedad Espanola De Oftalmologia Medicine-Ophthalmology

CiteScore

1.20

自引率

0.00%

发文量

109

审稿时长

78 days

期刊介绍： La revista Archivos de la Sociedad Española de Oftalmología, editada mensualmente por la propia Sociedad, tiene como objetivo publicar trabajos de investigación básica y clínica como artículos originales; casos clínicos, innovaciones técnicas y correlaciones clinicopatológicas en forma de comunicaciones cortas; editoriales; revisiones; cartas al editor; comentarios de libros; información de eventos; noticias personales y anuncios comerciales, así como trabajos de temas históricos y motivos inconográficos relacionados con la Oftalmología. El título abreviado es Arch Soc Esp Oftalmol, y debe ser utilizado en bibliografías, notas a pie de página y referencias bibliográficas.